Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Mablink Bioscience
company
About
Mablink Bioscience is a biotechnology company.
- 1 - 10
Highlights
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- €4M
- Industries
- Biotechnology,Pharmaceutical
- Founded date
- Jan 1, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Mablink Bioscience is a biotechnology company specialized in the development of a new class of cancer drugs, called Antibody Drug Conjugate (ADC).
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€4M
Mablink Bioscience has raised a total of
€4M
in funding over 2 rounds. Their latest funding was raised on
Apr 27, 2021 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 27, 2021 | Seed | €4M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Mablink Bioscience is funded by 1 investors.
Pertinence Invest
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Pertinence Invest
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
